# Phase 57A — Commercial Intelligence Integrity Report

**Internal only** — do not expose testing language in customer UX.

Generated: 2026-08-23T03:37:30.279Z

## Ingestion
- Data successfully ingested: **Yes**
- Snapshot ID: `snap_udg_a4d04dc9_mt59atih`
- Records: 476
- Source kind: excel
- Validation status: passed

## Profile
- Detected / confirmed: **Commercial Executive Intelligence**
- Confidence: 96%
- Not Manufacturing: **confirmed**

## Fields mapped
- Opportunity Name → Opportunity
- Opportunity Owner → Owner
- Product Family → Product
- Stage → Stage
- Transaction Type → Transaction
- Net SaaS (converted) Currency → Currency
- Net SaaS (converted) → SaaS Value
- Net Maintenance (converted) → Maintenance Value
- Net Software License (converted) → Software License Value
- Net One Time Services (converted) → One Time Services
- Net Recurring Services (converted) → Recurring Value
- Last Stage Change Date → Last Stage Change
- Stage Duration → Stage Duration
- Next Step → Next Step
- Industry → Industry
- Close Date → Close Date

## Data readiness (quality ≠ decision confidence)
- Data quality: 98%
- Data coverage: 94%
- Data freshness: 100%
- Evidence coverage: 79%
- Confidence: 96%
- Relationship integrity: 100%
- Commercial Dataset Readiness: **98%**
- Executive Readiness: **79%**
- Judgement readiness:
  - Commercial Dataset Readiness: high.
  - Activity-based judgement: insufficient evidence (Next Step coverage 0%).
- Recommendations:
  - (now) Restore activity evidence — Next Step coverage is too thin for activity-based commercial judgement — do not equate dataset cleanliness with decision confidence.

## Insights generated
- **Next-step evidence is thin** [data_quality] · insufficient_evidence · confidence 90%
  - Activity evidence for what should happen next is largely absent — commercial judgement cannot rely on next-step narrative.
  - Implication: Activity-based judgement is insufficient. Do not treat the dataset as decision-complete for next-step or activity cadence claims.
  - Evidence: 0/476 records carry Next Step.
- **Open opportunities are ageing in stage** [stale_opportunity] · investigate · confidence 90%
  - 53 open opportunities exceed the stage-duration threshold (≥ 120 days). Average open stage duration is 142 days.
  - Implication: 53 open opportunities exceed the stage-duration threshold. This may create forecast exposure and requires CRO judgement on which opportunities remain credible.
  - Evidence: 53/135 open records exceed duration threshold. | Stage Duration present on 135/135 open records. | Ageing open value in view ≈ 4,565,355 (pipeline in view — not value at risk).
- **Open records carry past close dates** [forecast_risk] · investigate · confidence 88%
  - 10 open records have Close Date before 2026-08-23. Forecast confidence should treat these as uncertain.
  - Implication: 10 open opportunities carry past close dates. Forecast confidence is constrained until CRO judgement confirms which remain credible.
  - Evidence: 10 open records with Close Date < 2026-08-23. | Past-close open value in view ≈ 269,375 (forecast exposure candidate — not claimed as value at risk).
- **Owner concentration is material** [concentration] · investigate · confidence 86%
  - David Beckett holds 65% of records (309).
  - Implication: David Beckett holds 65% of the commercial book. Concentration elevates single-book exposure and requires CRO judgement on coverage risk — without inventing conversion or churn probabilities.
  - Evidence: David Beckett: 65% (309) | Andy Foster: 10% (47) | Manesh Magan: 9% (42)
- **Product family concentration is material** [concentration] · monitor · confidence 88%
  - RedEye represents 33% of records.
  - Implication: RedEye concentration is material. Portfolio diversity and product-risk judgement sit with CRO/CSO — no conversion probability is inferred.
  - Evidence: RedEye: 33% | Maintenance Connection: 22% | Meridian: 19%
- **Open commercial book requires judgement** [pipeline_risk] · act · confidence 100%
  - 135 open records · pipeline in view ≈ 12,039,451 · recurring/SaaS open ≈ 7,387,071.
  - Implication: 135 open opportunities remain in the commercial book. Pipeline in view is evidenced; conversion probability and value protected are not claimed without further evidence.
  - Evidence: Open 135 / Closed 341 | Stage mix: Stage 3 - Discovery (73); Stage 4 - Evaluation (33); Stage 5 - Developing (14); Stage 6 - Favored (7)
- **Active-stage volume is material** [stage_risk] · monitor · confidence 84%
  - 135 records sit in active commercial stages — conversion and stage hygiene matter.
  - Implication: 135 opportunities sit in active stages. Stage hygiene and forecast credibility require CRO attention — conversion rates are not invented from this snapshot.
  - Evidence: Stage 3 - Discovery: 73 | Stage 4 - Evaluation: 33 | Stage 5 - Developing: 14 | Stage 6 - Favored: 7 | Stage 7 - Procurement: 6

## Recommendations generated
- Investigate: Open opportunities are ageing in stage (90% confidence) — 53 open opportunities exceed the stage-duration threshold. This may create forecast exposure and requires CRO judgement on which opportunities remain credible.
- Investigate: Open records carry past close dates (88% confidence) — 10 open opportunities carry past close dates. Forecast confidence is constrained until CRO judgement confirms which remain credible.
- Investigate: Owner concentration is material (86% confidence) — David Beckett holds 65% of the commercial book. Concentration elevates single-book exposure and requires CRO judgement on coverage risk — without inventing conversion or churn probabilities.
- Consider acting on: Open commercial book requires judgement (100% confidence) — 135 open opportunities remain in the commercial book. Pipeline in view is evidenced; conversion probability and value protected are not claimed without further evidence.
- Investigate: Judgement: Open opportunities are ageing in stage (90% confidence) — 53 open opportunities exceed the stage-duration threshold. This may create forecast exposure and requires CRO judgement on which opportunities remain credible.
- Insufficient evidence: Next-step evidence is thin — do not manufacture certainty.

## Confidence
- Brief confidence: 83%
- Data confidence narrative: Data quality 98% · Coverage 94% · Freshness 100% · Evidence coverage 79%. Commercial Dataset Readiness 98% · Executive Readiness 79%. Commercial Dataset Readiness: high. Activity-based judgement: insufficient evidence (Next Step coverage 0%). High data quality does not equal high decision confidence when critical evidence fields are absent.

## Evidence coverage
- opportunity: 100% (476/476)
- owner: 100% (476/476)
- product: 95% (454/476)
- stage: 100% (476/476)
- transactionType: 99% (469/476)
- saasValue: 100% (476/476)
- maintenanceValue: 100% (476/476)
- licenseValue: 100% (476/476)
- oneTimeServicesValue: 100% (476/476)
- recurringValue: 100% (476/476)
- lastStageChangeDate: 94% (448/476)
- stageDuration: 100% (476/476)
- nextStep: 0% (0/476)
- industry: 92% (440/476)
- closeDate: 100% (476/476)

## Missing information
- Next Step is sparsely populated (0% coverage).

## Unsupported conclusions
- Activity-evidence conclusions are unsupported — no Activity Evidence field is present in the snapshot.
- Value Protected and Value at Risk are not claimed — no defensible win/loss or risk-probability calculation is evidenced in this snapshot.

## Council (permanent five seats only)
- Seats: CEO · CFO · COO · CRO · CSO
- Framing: Executive Council is split on 2 material point(s) — disagreement is preserved for your judgement.
- Perspectives: CEO, CFO, COO, CRO, CSO
- Project / Decision tempo
  - Chief Financial Officer (delay): Revenue/margin Outcomes, forecast confidence, or cash collection are under pressure — binding spend now raises commercial risk.
  - Chief Operating Officer (proceed): Operating Outcomes or live delivery pressure require action — delay increases delivery risk more than it buys clarity.
  - Chief Executive Officer (escalate): Escalate to executive review — both commercial caution and delivery urgency are material.
- Decision path: Delay capital-heavy commitment until commercial evidence firms vs Unblock the commercial Decision to protect growth
  - Chief Financial Officer (delay): Revenue/margin Outcomes, forecast confidence, or cash collection are under pressure — binding spend now raises commercial risk.
  - Chief Revenue Officer (proceed): Customer/revenue Outcomes or live commercial pressure require action — delay cedes the window.

## Executive Brief generated
- Title: Commercial Executive Brief
- Executive Judgement: Strategic priorities have not yet been established. Judgement is ranked by materiality, evidence, confidence and potential business impact. Priority judgement: 53 open opportunities exceed the stage-duration threshold. This may create forecast exposure and requires CRO judgement on which opportunities remain credible. 135 open / 341 closed records in the Executive Snapshot.
- Evidence:
  - Open opportunities are ageing in stage: 53/135 open records exceed duration threshold. · Stage Duration present on 135/135 open records. · Ageing open value in view ≈ 4,565,355 (pipeline in view — not value at risk).
  - Open records carry past close dates: 10 open records with Close Date < 2026-08-23. · Past-close open value in view ≈ 269,375 (forecast exposure candidate — not claimed as value at risk).
  - Owner concentration is material: David Beckett: 65% (309) · Andy Foster: 10% (47) · Manesh Magan: 9% (42)
  - Product family concentration is material: RedEye: 33% · Maintenance Connection: 22% · Meridian: 19%
  - Open commercial book requires judgement: Open 135 / Closed 341 · Stage mix: Stage 3 - Discovery (73); Stage 4 - Evaluation (33); Stage 5 - Developing (14); Stage 6 - Favored (7)
  - Active-stage volume is material: Stage 3 - Discovery: 73 · Stage 4 - Evaluation: 33 · Stage 5 - Developing: 14 · Stage 6 - Favored: 7 · Stage 7 - Procurement: 6
  - Next-step evidence is thin: 0/476 records carry Next Step.
- Business Implication: 53 open opportunities exceed the stage-duration threshold. This may create forecast exposure and requires CRO judgement on which opportunities remain credible. 10 open opportunities carry past close dates. Forecast confidence is constrained until CRO judgement confirms which remain credible. David Beckett holds 65% of the commercial book. Concentration elevates single-book exposure and requires CRO judgement on coverage risk — without inventing conversion or churn probabilities. RedEye concentration is material. Portfolio diversity and product-risk judgement sit with CRO/CSO — no conversion probability is inferred.
- Council Position: Executive Council is split on 2 material point(s) — disagreement is preserved for your judgement.
- Uncertainty:
  - Next Step is sparsely populated (0% coverage).
  - Activity-evidence conclusions are unsupported — no Activity Evidence field is present in the snapshot.
  - Value Protected and Value at Risk are not claimed — no defensible win/loss or risk-probability calculation is evidenced in this snapshot.
  - Activity-based judgement: insufficient evidence (Next Step coverage 0%).
- Recommended Judgement:
  - Investigate: Open opportunities are ageing in stage (90% confidence) — 53 open opportunities exceed the stage-duration threshold. This may create forecast exposure and requires CRO judgement on which opportunities remain credible.
  - Investigate: Open records carry past close dates (88% confidence) — 10 open opportunities carry past close dates. Forecast confidence is constrained until CRO judgement confirms which remain credible.
  - Investigate: Owner concentration is material (86% confidence) — David Beckett holds 65% of the commercial book. Concentration elevates single-book exposure and requires CRO judgement on coverage risk — without inventing conversion or churn probabilities.
  - Consider acting on: Open commercial book requires judgement (100% confidence) — 135 open opportunities remain in the commercial book. Pipeline in view is evidenced; conversion probability and value protected are not claimed without further evidence.
  - Investigate: Judgement: Open opportunities are ageing in stage (90% confidence) — 53 open opportunities exceed the stage-duration threshold. This may create forecast exposure and requires CRO judgement on which opportunities remain credible.
  - Insufficient evidence: Next-step evidence is thin — do not manufacture certainty.
- Executive Value: Pipeline in View ≈ 12,039,451 (evidence-based sum of mapped open value fields). Forecast Exposure candidate ≈ 4,834,730 (past-close + ageing open value in view — not claimed as Value at Risk). Executive value not yet quantified for Value at Risk / Value Protected — no defensible probability model is evidenced.
- Data Confidence: Data quality 98% · Coverage 94% · Freshness 100% · Evidence coverage 79%. Commercial Dataset Readiness 98% · Executive Readiness 79%. Commercial Dataset Readiness: high. Activity-based judgement: insufficient evidence (Next Step coverage 0%). High data quality does not equal high decision confidence when critical evidence fields are absent.
- Commercial health: Attention Required — commercial interpretation from snapshot evidence. Commercial Dataset Readiness: high.
- Pipeline: Pipeline in View ≈ 12,039,451 across 135 open records. Stage mix is evidenced; CRM administration is out of scope.
- Forecast confidence: Executive Readiness 79% · Dataset readiness 98% · Insight confidence 90%. Forecast/opportunity evidence: sufficient. Activity judgement: insufficient.

## Command Centre
- Launch: `/today` (existing Mission Control — intelligence layer, not CRM)
- Prioritises narrative, pipeline health, forecast confidence, concentration, ageing, council — not opportunity tables.
- Active studio context saved for handoff (presentation store only).

---

ExecutiveOS remains an intelligence layer above systems of record — not a CRM.